Don't Be a Fool—Don't Use Fool's Gold - 20/09/12
Doi : 10.1016/j.amjmed.2012.03.019
Karen Woolley, BHMS Ed Hons PhD a, b, c, Art Gertel, BA, BS, MS d, Cindy Hamilton, PharmD e, Adam Jacobs, PhD, MSc f, Gene Snyder, MBA g
Global Alliance of Publication Professionals (www.gappteam.org)
a University of Queensland, Brisbane, QLD, Australia
b University of the Sunshine Coast, Sippy Downs, QLD, Australia
c ProScribe Medical Communications, Noosaville, QLD, Australia
d Beardsworth Consulting Group, Inc., Flemington, NJ
e Virginia Commonwealth University School of Pharmacy, Richmond, Va; Hamilton House, Virginia Beach, Va
f Dianthus Medical Limited, London, UK
g FoxP2 Consulting LLC, Clinton, NJ
Le texte complet de cet article est disponible en PDF.
| Funding: None. |
|
| Conflict of Interest: All authors have declared their conflicts of interest in a separate document (as per the Journal's guidelines; filename=MS12-219 GAPP Am J Med. COI Disclosures 13 Mar 2012). |
|
| Authorship: All authors had access to the data (ie, information used to develop this Letter) and all authors had a role in writing this Letter. |
© 2012
Elsevier Inc. Tous droits réservés.
Vol 125 - N° 10
P. e21-e22 - octobre 2012 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?